Evidence map›Paper›PMID 24012068›Full record

ArticleJournal of affective disorders2013

Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: a five-year longitudinal analysis.

Jessica L Montoya, Anya Umlauf, Ian Abramson, Jayraan Badiee, Steven Paul Woods, J Hampton Atkinson, Igor Grant, David J Moore, TMARC Group

Abstract read
In one paragraph

Article in Journal of affective disorders, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Leukocyte telomere length is not shortened in methamphetamine dependence or methamphetamine-induced psychosis but is increased following traumatic events.The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jessica L MontoyaSDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, USA.
Anya UmlaufUniversity of California, San Diego, School of Medicine, Department of Psychiatry, La Jolla, CA, USA.
Ian AbramsonUniversity of California, San Diego, Department of Mathematics, La Jolla, CA, USA.
Jayraan BadieeUniversity of California, San Diego, School of Medicine, Department of Psychiatry, La Jolla, CA, USA.
Steven Paul WoodsUniversity of California, San Diego, School of Medicine, Department of Psychiatry, La Jolla, CA, USA.
J Hampton AtkinsonUniversity of California, San Diego, School of Medicine, Department of Psychiatry, La Jolla, CA, USA; VA San Diego Healthcare System, San Diego, CA, USA.
Igor GrantUniversity of California, San Diego, School of Medicine, Department of Psychiatry, La Jolla, CA, USA.
David J MooreUniversity of California, San Diego, School of Medicine, Department of Psychiatry, La Jolla, CA, USA. Electronic address: djmoore@ucsd.edu.
TMARC Group

Funding

Translational Methamphetamine AIDS Research Center (TMARC)P50DA026306 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GRANT, IGOR · 2009 to 2018
$33.9M
Transnasal Delivery of Chemokine Analogs in mouse NeuroAIDS ModelsR21NS083415 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI LIPTON, STUART A · 2013 to 2014
$534k
NIDA NIH HHS P50 DA026306NIDA NIH HHS P50DA026306NINDS NIH HHS R21 NS083415
6 · The paper itself

Abstract

backgroundMethamphetamine (METH) use and human immunodeficiency virus (HIV) infection are highly comorbid, and both are associated with increased prevalence of affective distress. Delineating the trajectory of affective distress in the context of METH dependence and HIV infection is important given the implications for everyday functional impairment, adverse health behaviors, and increased risk for adverse health outcomes.

methodsWe conducted a five-year longitudinal investigation involving 133 METH-dependent (74 HIV seropositive) and 163 non-METH-dependent (90 HIV seropositive) persons to examine both long-standing patterns and transient changes in affective distress. Mixed-effect regression models with random subject-specific slopes and intercepts evaluated the effect of METH dependence, HIV serostatus, and related variables on affective distress, as measured by the Profile of Mood States.

resultsTransient changes in affective distress were found to be greater among those with a diagnosis of current MDD, briefer durations of abstinence from METH, and higher quantity of METH consumed. Weak associations were observed among static (time-independent predictors) covariates and long-standing patterns in affective distress. LIMITATIONS: Study lacked data pertaining to the participants' involvement in METH treatment and relied on respondent-driven sampling.

conclusionsOur longitudinal investigation of the trajectory of affective distress indicated that specific and dynamic indices of current METH use were associated with greater transient changes in mood. In the evaluation and treatment of affective distress, recency and quantity of current METH use are important to consider given their association with heightened affective distress and mood instability over time.

Indexed as

AdultAffectAmphetamine-Related DisordersFemaleHIV InfectionsHumansLongitudinal StudiesMaleMethamphetamineMiddle AgedStress, PsychologicalYoung AdultMethamphetamineAffective distressHIVLongitudinalMethamphetamine dependence

Identifiers

PMID24012068
PMCPMC3845675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.